Skip to main content
Indian Journal of Endocrinology and Metabolism logoLink to Indian Journal of Endocrinology and Metabolism
letter
. 2014 Jul-Aug;18(4):590–591. doi: 10.4103/2230-8210.137507

Thyroid acropachy: Frequently overlooked finding

Manish Gutch 1,, Saran Sanjay 1, Syed Mohd Razi 1, Keshav Kumar Gupta 1
PMCID: PMC4138926  PMID: 25143927

Sir,

Thyroid acropachy is an uncommon manifestation of autoimmune thyroid disorder, which has been reported recently in the journal of Indian Journal of Endocrinology and Metabolism[1] and in other Indian journals. It usually presents with clubbing and swelling of digits along with periosteal reaction of extremity bones. It is almost associated with ophthalmopathy and thyroid dermopathy. Thyroid acropachy is the least common manifestation of autoimmune thyroid disease. An epidemiological-based study showed that about 4% of patients with ophthalmopathy have dermopathy, and that one of five patients with dermopathy has acropachy. Acropachy is mostly associated with dermopathy and ophthalmopathy, although an isolated case of acropachy without dermopathy has been reported.[2] It can occur in all form of autoimmune thyroid disorder whether euthyroid, hypothyroid or hyperthyroid patients.[2] Patients first develop thyroid dysfunction, followed by ophthalmopathy, then dermopathy, and finally, acropachy.[2]

However, the reports suggest that thyroid acropachy may be more common. The ubiquitous prevalence of clubbing secondary to pulmonary causes may lead primary care physicians to miss the diagnosis of thyroid acropachy in India. This letter highlights some differences between clubbing and periostitis seen in thyroid acropachy and clubbing and pulmonary osteoarthropathy seen in lung and other systemic and paraneoplastic conditions. [Table 1] Thyroid acropachy is distinguished by the uniform presence of thyroid dermopathy and ophthalmopathy. Radiological features are also somewhat different; in patients with thyroid acropachy, there is less involvement of the long bones. In pulmonary osteoarthropathy, periosteal reaction usually is symmetric; in acropachy, it can be asymmetric. In acropachy, radiographs show a characteristic sub-periosteal spiculated, frothy, or lacy appearance,[3] quite different from the laminal periosteal proliferation of classic pulmonary osteoarthropathy. However, in thyroid acropachy, other mechanisms (such as autoimmune phenomena and increased glycosaminoglycan and fibroblast proliferation similar to changes in thyroid ophthalmopathy and dermopathy) may be at work.[1,4] It is usually believed that the periosteal reaction in thyroid acropachy, unlike that in pulmonary osteoarthropathy does not occur in the long bones of the forearms or the legs. Dermopathy is indicative of a severe autoimmune thyroid disease; acropachy is likely to indicate an even more severe form. In patients with thyroid acropachy, skin biopsy demonstrates typical findings of pretibial myxedema, including fibroblast activation and glycosaminoglycan deposition. Similar findings have been noted in skin overlying periosteal changes of acropachy.[4]

Table 1.

Difference between thyroid acropachy and other disorder associated with clubbing and pulmonary osteoarthropathy

graphic file with name IJEM-18-590-g001.jpg

No specific treatment for acropachy of thyroid disease is available, other than systemic immunosuppressive therapy and local corticosteroid therapy. These treatments usually are directed at associated ophthalmopathy and dermopathy. For persistent pulmonary osteoarthropathy, local octreotide injection and local radiotherapy have been tried. Whether these measures would help the patients with thyroid acropachy are unclear.[1,5]

ACKNOWLEDGMENT

We owe thanks to the patient and her relatives for having patience and their contribution to this undertaking.

REFERENCES

  • 1.Reddy SB, Gupta SK, Jain M. Dermopathy of Graves’ disease: Clinico-pathological correlation. Indian J Endocrinol Metab. 2012;16:460–2. doi: 10.4103/2230-8210.95714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Fatourechi V, Ahmed DD, Schwartz KM. Thyroid acropachy: Report of 40 patients treated at a single institution in a 26-year period. J Clin Endocrinol Metab. 2002;87:5435–41. doi: 10.1210/jc.2002-020746. [DOI] [PubMed] [Google Scholar]
  • 3.Vanhoenacker FM, Pelckmans MC, De Beuckeleer LH, Colpaert CG, De Schepper AM. Thyroid acropachy: Correlation of imaging and pathology. Eur Radiol. 2001;11:1058–62. doi: 10.1007/s003300000735. [DOI] [PubMed] [Google Scholar]
  • 4.Fatourechi V. Thyroid dermopathy and acropachy. Expert Rev Dermatol. 2011;6:75–905. [Google Scholar]
  • 5.Rotman-Pikielny P, Brucker-Davis F, Turner ML, Sarlis NJ, Skarulis MC. Lack of effect of long-term octreotide therapy in severe thyroid-associated dermopathy. Thyroid. 2003;13:465–70. doi: 10.1089/105072503322021124. [DOI] [PubMed] [Google Scholar]

Articles from Indian Journal of Endocrinology and Metabolism are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES